TY  - GEN
AU  - Girard,C
TI  - [Brodalumab]
SN  - 0151-9638
PY  - 2020///0127
KW  - Antibodies, Monoclonal, Humanized
KW  - pharmacology
KW  - Contraindications, Drug
KW  - Dermatologic Agents
KW  - Drug Monitoring
KW  - Humans
KW  - Psoriasis
KW  - drug therapy
KW  - Receptors, Interleukin-17
KW  - immunology
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.annder.2019.04.001
ER  -